Priyanka Sharma

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 41

Top Topics

Sentinel Lymph Node

Metastatic Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ breast cancer

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-infiltrating lymphocytes refine outcomes in triple-negative breast cancer treated with anthracycline-free neoadjuvant chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Patricia A Ganz, Hanna Bandos, Tanja Španić, Sue Friedman, Volkmar Mueller, Sherko Kuemmel, Suzette Delaloge, Etienne G C Brain, Masakazu Toi, Hideko Yamauchi, E Martínez de Dueñas, Anne Armstrong, Seock-Ah Im, Chuan-Gui Song, Hong Zheng, Tomasz Sarosiek, Priyanka Sharma, Cuizhi Geng, Peifen Fu, Kerstin Rhiem, Heike Frauchiger-Heuer, Pauline Wimberger, Daphné t'Kint de Roodenbeke, Ning Liao, Annabel Goodwin, Camille Chakiba-Brugère, Michael L Friedlander, Keun Seok Lee, Sylvie Giacchetti, Toshimi Takano, Fernando Henao, Shamsuddin Virani, Frances Valdes-Albini, Susan M Domchek, Charles Bane, Edward C McCarron, Monica Mita, Giovanna Rossi, Priya Rastogi, Anitra Fielding, Richard D Gelber, Elsemieke D Scheepers, David A Cameron, Judy E Garber, Charles E Geyer, Andrew N J Tutt
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-infiltrating lymphocytes refine outcomes in triple-negative breast cancer treated with anthracycline-free neoadjuvant chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mariana Chavez Mac Gregor, Jieling Miao, Lajos Pusztai, Matthew P Goetz, Priya Rastogi, Patricia A Ganz, Eleftherios P P Mamounas, Soonmyung Paik, Hanna Bandos, Wajeeha Razaq, Anne O'Dea, Virginia G Kaklamani, Andrea L M Silber, Lisa E Flaum, Eleni Andreopoulou, Albert G Wendt, Jennifer F Carney, Priyanka Sharma, Julie R Gralow, Danika L Lew, William E Barlow, Gabriel N Hortobagyi
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Erica L Mayer, Yue Ren, Nikhil Wagle, Reshma L Mahtani, Cynthia X Ma, Angela M DeMichele, Massimo Cristofanilli, Jane Meisel, Kathy D Miller, Yara G Abdou, Elizabeth C Riley, Rubina Qamar, Priyanka Sharma, Sonya A Reid, Natalie Sinclair, Meredith Faggen, Caroline C Block, Naomi Y Ko, Ann H Partridge, Wendy Y Chen, Michelle DeMeo, Victoria Attaya, Amanda Okpoebo, Jillian Alberti, Yuan Liu, Eric Gauthier, Harold J Burstein, Meredith M Regan, Sara M Tolaney
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Qamar J Khan, Anne P O'Dea, Lauren E Nye, Manana Elia, Jaimie Heldstab, Trisha Home, Stephen Hyter, Kamilla Isakova, Harsh B Pathak, Andrew K Godwin, Priyanka Sharma
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. NPJ breast cancer 9 (1) (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Qamar J Khan, Anne P O'Dea, Lauren E Nye, Manana Elia, Jaimie Heldstab, Trisha Home, Stephen Hyter, Kamilla Isakova, Harsh B Pathak, Andrew K Godwin, Priyanka Sharma
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. NPJ breast cancer 9 (1) (2023)
Jennifer K Plichta, Samantha M Thomas, Daniel F Hayes, Mariana Chavez Mac Gregor, Kimberly Allison, Jennifer de Los Santos, Amy M Fowler, Armando E Giuliano, Priyanka Sharma, Benjamin D Smith, Elizabeth van Eycken, Stephen B Edge, Gabriel N Hortobagyi
Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Qamar J Khan, Anne P O'Dea, Lauren E Nye, Manana Elia, Jaimie Heldstab, Trisha Home, Stephen Hyter, Kamilla Isakova, Harsh B Pathak, Andrew K Godwin, Priyanka Sharma
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. NPJ breast cancer 9 (1) (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Shane R Stecklein, Bruce F Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M Staley, Qamar J Khan, Anne P O'Dea, Lauren E Nye, Manana Elia, Jaimie Heldstab, Trisha Home, Stephen Hyter, Kamilla Isakova, Harsh B Pathak, Andrew K Godwin, Priyanka Sharma
ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. NPJ breast cancer 9 (1) (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Shane R Stecklein, William E Barlow, Lajos Pusztai, Kirsten Timms, Richard D Kennedy, Gemma E Logan, Robert S Seitz, Sunil S Badve, Yesim Gökmen-Polar, Peggy Porter, Hannah Linden, Debasish Tripathy, Gabriel N Hortobagyi, Andrew K Godwin, Alastair Thompson, Daniel F Hayes, Priyanka Sharma
Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency. JCO precision oncology 7 (2023)
Corey W Speers, William Fraser Symmans, William E Barlow, Alexander J Trevarton, Stephanie The, Lili Du, James M Rae, Steven Shak, Frederick L Baehner, Priyanka Sharma, Lajos Pusztai, Gabriel N Hortobagyi, Daniel F Hayes, Kathy S Albain, Andrew K Godwin, Alastair Thompson
Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Afroditi Nanou, Jieling Miao, Frank A W Coumans, Emily M Dolce, Elizabeth Darga, William E Barlow, Jeffrey B Smerage, Costanza Paoletti, Andrew K Godwin, Lajos Pusztai, Priyanka Sharma, Alastair Thompson, Gabriel N Hortobagyi, Leon W M M Terstappen, Daniel F Hayes
Tumor-Derived Extracellular Vesicles as Complementary Prognostic Factors to Circulating Tumor Cells in Metastatic Breast Cancer. JCO precision oncology 7 (2023)
Priyanka Sharma
Time to Optimize Deescalation Strategies in Triple-Negative Breast Cancer? Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Norah L Henry, Mark R Somerfield, Zoneddy Dayao, Anthony D Elias, Kevin Kalinsky, Lisa Meier McShane, Beverly Moy, Ben Ho Park, Kelly M Shanahan, Priyanka Sharma, Rebecca Shatsky, Erica M Stringer-Reasor, Melinda Telli, Nicholas C Turner, Angela M DeMichele
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Nour Abuhadra, Shane Stecklein, Priyanka Sharma, Stacy Moulder
Early-stage Triple-negative Breast Cancer: Time to Optimize Personalized Strategies. The oncologist 27 (1) (2022)
Rachel Yoder, Bruce F Kimler, Joshua M Staley, Kelsey Schwensen, Yen Y Wang, Karissa Finke, Anne O'Dea, Lauren Nye, Manana Elia, Gregory Crane, Richard McKittrick, Robert Pluenneke, Sheshadri Madhusudhana, Larry Beck, Anuj Shrestha, Larry Corum, Mark Marsico, Shane R Stecklein, Andrew K Godwin, Qamar J Khan, Priyanka Sharma
Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer. NPJ breast cancer 8 (1) (2022)